Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 28, 2025 | (Q2)Jun 29, 2025 | (Q1)Mar 30, 2025 | (FY)Dec 29, 2024 | (Q4)Dec 29, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -63.91%463K | 95.50%-30K | 59.31%1.2M | 202.25%2.64M | 295.64%1.27M | 188.30%1.28M | -240.31%-667K | 145.03%752K | -87.50%-2.58M | 278.33%321K |
| Net income from continuing operations | 140.35%684K | 75.70%1.01M | 244.93%238K | 72.49%-1.3M | 94.05%-241K | -465.30%-1.7M | 494.48%572K | 117.92%69K | 38.09%-4.71M | -455.97%-4.05M |
| Operating gains losses | --0 | ---- | ---- | ---1.01M | ---170K | --0 | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -6.54%286K | -15.74%289K | -15.25%289K | 0.71%1.27M | -24.13%283K | 171.66%306K | -48.81%343K | 19.65%341K | 962.18%1.26M | 133.48%373K |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -98.66%66K | ---- |
| Remuneration paid in stock | -54.29%16K | 300.00%4K | -30.00%14K | -25.61%61K | -52.94%8K | 250.00%35K | -107.41%-2K | -28.57%20K | -78.87%82K | -95.45%17K |
| Other non cashItems | -91.42%189K | -55.56%12K | -61.29%12K | -31.17%2.86M | -80.05%593K | 133.72%2.2M | -67.86%27K | -59.74%31K | 138,166.67%4.15M | 1,247.49%2.97M |
| Change In working capital | -264.43%-712K | -29.19%-987K | 121.65%645K | 122.05%757K | -22.02%797K | 117.42%433K | 11.68%-764K | 117.37%291K | -252.78%-3.43M | -52.18%1.02M |
| -Change in receivables | -21.21%364K | -565.38%-121K | -145.54%-204K | 124.38%503K | -362.42%-433K | 134.53%462K | 102.49%26K | 186.49%448K | -2,342.39%-2.06M | 560.00%165K |
| -Change in inventory | --0 | ---- | ---- | 8,000.00%81K | 28.00%64K | 106.04%9K | ---- | -111.11%-19K | -99.82%1K | -91.47%50K |
| -Change in prepaid assets | 87.50%30K | 33.33%-30K | 90.80%-15K | -476.47%-196K | -109.76%-4K | 100.00%16K | -4.65%-45K | -262.22%-163K | -141.98%-34K | -84.70%41K |
| -Change in payables and accrued expense | -386.27%-876K | 49.20%-349K | 128.28%226K | 149.96%671K | 205.45%953K | 145.47%306K | -452.31%-687K | 109.30%99K | -375.77%-1.34M | 26.83%312K |
| -Change in other working capital | 36.11%-230K | -619.70%-475K | 786.02%638K | -5,133.33%-302K | -52.20%217K | -7.78%-360K | 15.38%-66K | -138.46%-93K | -99.42%6K | -55.14%454K |
| Cash from discontinued investing activities | 83.01%-175K | 272.50%138K | 97.57%-33K | -282.26%-2.92M | -296.49%-448K | -1.03M | -80K | -425.36%-1.36M | 149.38%1.6M | 228K |
| Operating cash flow | 13.83%288K | 114.46%108K | 291.61%1.17M | 71.40%-280K | 49.73%822K | 416.25%253K | -281.12%-747K | 51.44%-608K | -33.38%-979K | 18.83%549K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 78.23%-32K | 34.14%1.06M | -5,070.00%-517K | 1,200.00%396K | -131.13%-235K | 75.13%-147K | 497.98%788K | -10K | 99.93%-36K | 101.51%755K |
| Net PPE purchase and sale | 78.23%-32K | 34.14%1.06M | -5,070.00%-517K | 1,200.00%396K | -132.68%-235K | 80.53%-147K | --788K | ---10K | -1,100.00%-36K | 684.55%719K |
| Cash from discontinued investing activities | 0 | 0 | 0 | 331.36%3.05M | 102.00%25K | -3K | -32K | 153,300.00%3.06M | -1,085.07%-1.32M | -1.25M |
| Investing cash flow | 78.67%-32K | 39.81%1.06M | -116.93%-517K | 354.42%3.45M | 57.49%-210K | 77.34%-150K | 481.82%756K | 152,800.00%3.05M | 97.28%-1.36M | 99.01%-494K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 11.50%-662K | -189.47%-1.76M | 32.88%-343K | -66.33%-2.01M | 76.60%-139K | -215.79%-748K | -1.67%-608K | -124.12%-511K | -102.07%-1.21M | -101.02%-594K |
| Net issuance payments of debt | 11.50%-662K | -189.47%-1.76M | 32.88%-343K | -66.33%-2.01M | 76.60%-139K | -215.79%-748K | -1.67%-608K | -124.12%-511K | -102.19%-1.21M | -101.09%-594K |
| Cash from discontinued financing activities | 77.78%-14K | 80.95%-12K | 85.44%-68K | 67.60%-555K | 108.88%38K | -63K | -63K | -8.10%-467K | -6.86%-1.71M | -428K |
| Financing cash flow | 16.65%-676K | -164.08%-1.77M | 57.98%-411K | 12.26%-2.56M | 90.12%-101K | -26.92%-811K | -12.21%-671K | -48.18%-978K | -105.27%-2.92M | -101.86%-1.02M |
| Net cash flow | ||||||||||
| Beginning cash position | -27.63%1.49M | -22.94%2.1M | 48.21%1.86M | -80.73%1.25M | -38.99%1.36M | -42.73%2.06M | -40.68%2.73M | -79.14%1.26M | 268.73%6.51M | 129.44%2.22M |
| Current changes in cash | 40.68%-420K | 8.31%-607K | -83.86%237K | 111.59%609K | 135.24%511K | 21.16%-708K | 33.27%-662K | 202.59%1.47M | -210.77%-5.25M | -126.17%-1.45M |
| End cash Position | -20.81%1.07M | -27.63%1.49M | -22.94%2.1M | 48.56%1.86M | 48.56%1.86M | -38.99%1.36M | -42.73%2.06M | -40.68%2.73M | -80.73%1.25M | -80.73%1.25M |
| Free cash from | 141.51%256K | 98.14%-14K | 204.85%648K | -1.38%-1.03M | -81.83%237K | 115.80%106K | -91.37%-754K | 50.64%-618K | -37.72%-1.02M | 150.29%1.3M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.